The final chapter has been written for behavioral healthcare company Ontrak, which formally filed for Chapter 7 bankruptcy on August 28, 2025. This action initiates a complete court-supervised liquidation of the company, resulting in a total loss for equity holders.
Operational Collapse Precedes Bankruptcy Filing
Ontrak’s downfall accelerated rapidly in the latter half of 2025. The company’s board unanimously approved a voluntary Chapter 7 petition and subsequently resigned en masse. This decision followed the complete cessation of all business operations on July 31, 2025, when Ontrak terminated its entire workforce after determining it could no longer meet financial covenants or secure necessary funding.
The critical blow came on July 2, 2025, when a major potential client terminated its partnership agreement. This lost contract represented access to approximately 29,000 insured members and would have provided crucial revenue that might have sustained operations.
Financial Metrics Signal Deepening Crisis
Ontrak’s financial deterioration was severe and persistent throughout 2024 and into 2025:
Should investors sell immediately? Or is it worth buying Ontrak?
- Cash depletion: The company’s liquidity position weakened dramatically, with cash reserves plummeting 41% from $9.7 million at year-end 2023 to just $5.7 million by the conclusion of 2024.
- Revenue decline: Full-year 2024 revenue decreased by 15% to $10.8 million, accompanied by a substantial net loss of $25.5 million.
- Q1 2025 performance: The negative trend intensified with revenue collapsing by 25% to merely $2.0 million for the first quarter.
Delisting and Failed Capital Raise
NASDAQ suspended trading of Ontrak shares on August 18, 2025, citing the company’s persistent failure to maintain the minimum $1 bid price requirement. The exchange classified Ontrak as a “Public Shell” and proceeded with delisting, a move the company did not contest. Ontrak had already been removed from the NASDAQ Composite Index on August 14 and the S&P TMI Index on August 20, with any remaining trading occurring only in the over-the-counter market.
Even a last-ditch financing effort proved insufficient to avert collapse. In late June 2025, Ontrak raised approximately $4 million through a combined stock and warrant offering, netting about $3.2 million after expenses. These funds were ultimately inadequate to address the company’s operational challenges and mounting losses.
Key Events Summary
- Business operations ceased: July 31, 2025
- Chapter 7 bankruptcy filed: August 28, 2025
- NASDAQ delisting: Trading suspension implemented August 18, 2025
- Major client loss: Affected potential enrollment of 29,000 insured members
- Liquidity decline: 41% reduction in cash reserves during 2024
The sequence of events—from the failed client partnership and insufficient capital raise to the delisting and final bankruptcy filing—illustrates the rapid and irreversible nature of Ontrak’s decline, highlighting the intense competitive pressures within the healthcare technology sector.
Ad
Ontrak Stock: Buy or Sell?! New Ontrak Analysis from February 7 delivers the answer:
The latest Ontrak figures speak for themselves: Urgent action needed for Ontrak investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Ontrak: Buy or sell? Read more here...
